دورية أكاديمية

Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis.

التفاصيل البيبلوغرافية
العنوان: Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis.
المؤلفون: Klotsche J; German Rheumatism Research Center, A Leibniz Institute, Berlin, Germany., Torok KS; University of Pittsburgh, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA., Kasapcopur O; Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey., Adrovic A; Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey., Terreri MT; Universidade Federal de São Paulo, Sao Paulo, Brazil., Sakamoto AP; Universidade Federal de São Paulo, Sao Paulo, Brazil., Katsicas M; Hospital de Pediatria J.P. Garrahan, Buenos Aires, Argentine., Sztajnbok F; Universidade do Estado, Rio de Janeiro, Brazil., Marrani E; Meyer Children's Hospital, Florence, Italy., Sifuentes-Giraldo A; University Hospital Ramón y Cajal, Madrid, Spain., Stanevicha V; Department of Pediatrics, Riga Stradins University, University Children Hospital, Riga, Latvia., Anton J; Pediatric Rheumatology, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain., Feldmann B; SickKids, The Hospital for Sick Children, Toronto, ON, Canada., Kostik M; Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Nemcova D; Charles University, Prague, Czech Republic., Santos MJ; Serviço de Reumatologia, Hospital Garcia de Orta, Almada, Portugal., Appenzeller S; School of Medical Science, State University of Campinas, Campinas, Brazil., Avcin T; University Children's Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia., Battagliotti C; Hospital de Niños Dr Orlando Alassia, Santa Fe, Argentine., Berntson L; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Bica B; Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Brunner J; Department of Pediatrics, Pediatric Rheumatology, Medical University Innsbruck, Innsbruck, Austria., Eleftheriou D; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Harel L; Schneider Children's Medical Center, Tel Aviv University, Petah Tikva, Israel., Horneff G; Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany., Kallinich T; Charité University Medicine and German Rheumatism Research Center Berlin, Berlin, Germany., Minden K; German Rheumatism Research Center, A Leibniz Institute, Berlin, Germany.; Charité University Medicine and German Rheumatism Research Center Berlin, Berlin, Germany., Nielsen S; Rigshospitalet, Copenhagen, Denmark., Patwardhan A; University of Missouri, Columbia, MO, USA., Helmus N; Hamburg Centre for Pediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany., Foeldvari I; Hamburg Centre for Pediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.
المصدر: Journal of scleroderma and related disorders [J Scleroderma Relat Disord] 2023 Oct; Vol. 8 (3), pp. 183-191. Date of Electronic Publication: 2023 Apr 10.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: SAGE Country of Publication: England NLM ID: 101685427 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2397-1991 (Electronic) Linking ISSN: 23971983 NLM ISO Abbreviation: J Scleroderma Relat Disord Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2018- : [London] : SAGE
Original Publication: 2016-2017: [Tarporley] : Wichtig International
مستخلص: Objectives: Juvenile systemic sclerosis is a rare childhood disease. Three disease activity indices have been published for adult patients with systemic sclerosis: the European Scleroderma Study Group Index, a modified version of the European Scleroderma Study Group Index and the revised European Scleroderma Trials and Research index. The objective of this study was to determine the feasibility and performance of the three disease activity indices in a prospectively followed cohort of patients with juvenile systemic sclerosis.
Methods: The analysis cohort was selected from the prospective international inception cohort enrolling juvenile systemic sclerosis patients. The correlation of the disease activity indices with the physicians' and the patients' global assessment of disease activity was determined. The disease activity indices were compared between patients with active and inactive disease. Sensitivity to change between 6- and 12-month follow-up was investigated by mixed models.
Results: Eighty percent of the 70 patients had a diffuse cutaneous subtype. The revised European Scleroderma Trials and Research index was highly correlated with the physician-reported global disease activity/parents-reported global disease activity (r = 0.74/0.64), followed by the European Scleroderma Study Group activity index (r = 0.61/0.55) and the modified version of the European Scleroderma Study Group activity index (r = 0.51/0.43). The disease activity indices significantly differed between active and inactive patients. The disease activity indices showed sensitivity to change between 6- and 12-month follow-up among patients who improved or worsened according to the physician-reported global disease activity and the parents-reported global disease activity.
Conclusion: Overall, no disease activity score is superior to the other, and all three scores have limitations in the application in juvenile systemic sclerosis patients. Furthermore, research on the concept of disease activity and suitable scores to measure disease activity in patients with juvenile systemic sclerosis is necessary in future.
Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: the editor/editorial board member of Journal of Scleroderma and Related Disorders is an author of this paper; therefore, the peer-review process was managed by alternative members of the board, and the submitting editor/board member had no involvement in the decision-making process.
(© The Author(s) 2023.)
References: Rheum Dis Clin North Am. 2003 May;29(2):255-73, vi. (PMID: 12841294)
Pediatr Rheumatol Online J. 2007 May 01;5:6. (PMID: 17550632)
Ann Rheum Dis. 2017 Jan;76(1):270-276. (PMID: 27621285)
J Rheumatol. 1988 Feb;15(2):202-5. (PMID: 3361530)
Arthritis Res Ther. 2016 Oct 22;18(1):246. (PMID: 27770830)
Semin Arthritis Rheum. 2007 Oct;37(2):93-8. (PMID: 17363039)
Pain. 1991 Dec;47(3):249-283. (PMID: 1784498)
Arthritis Rheum. 2007 Mar 15;57(2):203-12. (PMID: 17330294)
J Scleroderma Relat Disord. 2019 Feb;4(1):49-61. (PMID: 35382144)
Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):53-58. (PMID: 32573412)
J Scleroderma Relat Disord. 2018 Jun;3(2):115-121. (PMID: 35382236)
Arthritis Care Res (Hoboken). 2010 Feb;62(2):213-8. (PMID: 20191520)
J Rheumatol. 1999 Oct;26(10):2159-67. (PMID: 10529133)
Rheumatology (Oxford). 2010 Jun;49(6):1133-45. (PMID: 20236952)
J Scleroderma Relat Disord. 2018 Jun;3(2):189-190. (PMID: 35382241)
Arthritis Rheum. 1994 Dec;37(12):1761-9. (PMID: 7986222)
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. (PMID: 27385265)
Ann Rheum Dis. 2001 Jun;60(6):592-8. (PMID: 11350848)
Semin Arthritis Rheum. 2017 Feb;46(4):473-487. (PMID: 27765344)
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18. (PMID: 28516167)
Ann Rheum Dis. 2013 Nov;72(11):1747-55. (PMID: 24092682)
Front Immunol. 2019 Jun 25;10:1352. (PMID: 31293569)
معلومات مُعتمدة: 21791 United Kingdom VAC_ Versus Arthritis
فهرسة مساهمة: Keywords: Systemic sclerosis; disease activity; juvenile systemic sclerosis
تواريخ الأحداث: Date Created: 20230925 Latest Revision: 20240313
رمز التحديث: 20240313
مُعرف محوري في PubMed: PMC10515993
DOI: 10.1177/23971983231164700
PMID: 37744052
قاعدة البيانات: MEDLINE
الوصف
تدمد:2397-1991
DOI:10.1177/23971983231164700